Day 2 :
Keynote Forum
Temitope H Farombi
University College Hospital Ibadan, Nigeria
Keynote: Profiling the non-motor symptoms burden in Parkinson’s disease patients in Nigeria using non-motor symptoms questionnaires
Time : 10:00-10:45

Biography:
Abstract:
- Neuro Pathology | Neuro Cardiology & Strokes, Neuro Chemistry | Nursing and Neuroscience | Ataxia | Neurogenetic Exploration | Psychiatry and Psychology | Epilepsy | Evaluation | Treatment & Management
Session Introduction
Shaheda Tabasum
Institute of Behavioral and Management Sciences, UAE
Title: Behavioral disorders in children
Time : 10:45-11:15

Biography:
Abstract:
Marzia Afrin Ali Meem
Jinan University International Medical School, China
Title: Dementia
Time : 11:30-12:00

Biography:
Abstract:
Vittorio Iantorno
Neuro Spinal Hospital (UAE)
Title: Hepatolenticular Degeneration
Time : 12:00-12:30

Biography:
Dr Vittorio Iantorno is a Consultant Neurologist with 20 Years of European experience in the Neurology field. He completed his study in Rome (Italy) and then moved to UK. He is Fellow of the Royal College of Physicians (FRCP- London, UK), Past Member of the Movement Disorder Society, Past-Councillor of Italian Medical Society of Great Britain and Member of the Emirates Neurological Society. He spent nearly two decades working in the United Kingdom in various prestigious Hospitals such as the Royal Free Hospital London and the Regional Neuroscience Centre at King’s College Hospital. For many years he served as the Head of Neurology Department for Heart of England NHS Trust - which is one of the largest Foundation Trusts in the West Midlands in UK - as Educational Co-ordinator for Neurology and also as the Chairperson of the local Movement Disorders/Parkinson’s Disease Operational Group. He has always been fascinated by Movement Disorders since early stage of his career especially by either the excess of movement or paucity of voluntary or involuntary movement patients experience with such conditions. He has been fundamental in setting Multidisciplinary Teams approach which he feels being a cornerstone in managing patients with Movement Disorders and he believes that such clinical conditions are an evolving field which will hopefully bring a better insight of the pathogenesis of the related diseases and improve clinical care for patients
Abstract:
Some Movement Disorders represent a challenging condition for Neurologists to diagnose and treat. The basal ganglia were originally thought to be associated purely with motor control. However, dysfunction and pathology of different regions and circuits are now known to give rise to many clinical manifestations beyond the association of basal ganglia dysfunction with movement disorders. Hepatolenticular Degeneration has for a long time been of particular interest to the Neurologists. It exemplifies a specific metabolic disorder involving some special relation between hepatic cirrhosis and degeneration of the brain. The disease is a microcosm of the history of neurology, beginning with seminal clinical observations followed by pioneering work translating a specific deficiency in sheep to human treatment, and continuing on to identification of causative gene mutations. For nearly half a century the cause of the disease remained unclear and patients continued to die without definitive treatment. Things changed rapidly once the clear pathogenesis was demonstrated. Recognition of the disorder is important because effective treatment can prevent or improve disease features.
Hashil Hatif Al Hatmi
Almaha Academy, Qatar
Title: The effect time perception and emotional interference on autobiographical memories
Time : 12:30-13:00
Biography:
Abstract:
Temitope H Farombi
University College Hospital Ibadan, Nigeria
Title: Neurogenetic and neurodegenerative in Africa
Time : 14:00-14:30

Biography:
Abstract:
Lamia F Alsubaie
King Abdulaziz Medical City, KSA
Title: Genomic testing and counseling: The contribution of next generation sequencing to epilepsy genetics
Time : 14:30-15:00
Biography:
Lamia F Alsubaie is a Senior Genetic Counselor at the National Guard Health Affairs in Riyadh, KSA since 2011 and part-time Instructor at Al-Faisal University, College of Medicine. She is working on variant calling and interpretation in genomic medicine since 2015. She holds a Master’s degree in Human Genetics and Genetic Counseling from Joan H. Marks-Human Genetic Program at Sarah Lawrence College in New York, USA. Her main areas of professional interest are cancer genetic counseling, genomic counseling and ethical challenges surrounding genetic testing and genetic information sharing.
Abstract:
Background: Next-generation sequencing (NGS) have become more accessible and widely available technology to detect genetic causations of diseases. While NGS technology has already benefited different clinical phenotypes, some areas have adapted less quickly than others, as in seizures and epileptic disorders, where genetic diagnosis were mainly based on epilepsy gene panels and not whole exome and/or genome sequencing. Method: We retrospectively analyzed 689 cases that have been sent for NGS over period of 18 months to investigate challenges in diagnosing epilepsy. Result: 74 (10.7%) cases out of 689 cases were sent for epilepsy, half of these cases have a positive family history. The results of NGS were divided as the following: 39 (52.7%) cases were negative, 26 positive cases (35%), and 11 inconclusive cases (14.8%). Out of the inconclusive and positive cases, only one gene has been detected twice in different cases. Comparative Genomic Hybridization (CGH) has been performed for all negative cases, only one case showed de novo duplication in 2q24.3. Conclusion: These findings have implications for our understanding of genetic testing approach and genetic counseling for patients affected with seizures and epilepsy disorders. The overall diagnostic yield of exome/genome sequencing in our cohort was 35%. And the main characteristics is genetic heterogeneity suggests NGS technology as suitable testing approach for seizures and epilepsy disorders. Genetic counseling for newly identified disease-causing variants depends on pedigree interpretation keeping in mind disease penetrance and variable expressivity.
Pousette Farouk
Ain Shams University, Egypt
Title: Assessment of cognitive functions in middle aged patients suffering from type 1 and type 2 diabetes mellitus
Time : 15:00-15:15

Biography:
Abstract:
Mehdi Fathi
Mashhad University, Iran
Title: Principals of hypnoanesthesia, hypnotic suggestion for intra and postoperative pain control
Time : 15:15-15:30
